Header Logo

Susan Conway

Concepts (137)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticoagulants
5
2017
293
1.840
Why?
beta-Alanine
4
2014
12
1.790
Why?
Benzimidazoles
4
2014
29
1.760
Why?
Education, Pharmacy
4
2014
108
1.110
Why?
Venous Thromboembolism
3
2014
133
1.090
Why?
Hemorrhage
4
2014
260
0.950
Why?
Students, Pharmacy
4
2013
78
0.910
Why?
Poison Control Centers
2
2014
2
0.900
Why?
Clinical Competence
3
2013
216
0.730
Why?
Vaccination
2
2023
175
0.700
Why?
Drug Monitoring
2
2017
34
0.640
Why?
Deprescriptions
1
2018
3
0.620
Why?
Proton Pump Inhibitors
1
2018
26
0.610
Why?
Curriculum
5
2013
271
0.560
Why?
Faculty, Medical
1
2017
51
0.550
Why?
Antithrombins
1
2017
28
0.550
Why?
Influenza, Human
2
2017
84
0.530
Why?
Hypoglycemic Agents
1
2017
106
0.510
Why?
Students, Medical
1
2017
95
0.510
Why?
Warfarin
2
2017
94
0.490
Why?
Students, Dental
1
2014
3
0.470
Why?
Education, Dental
1
2014
7
0.470
Why?
Thiophenes
1
2014
14
0.470
Why?
Morpholines
1
2014
27
0.470
Why?
Humans
23
2023
27121
0.460
Why?
Thrombophilia
1
2014
10
0.450
Why?
Blood Coagulation
2
2013
116
0.450
Why?
Factor Xa Inhibitors
1
2014
53
0.450
Why?
Student Health Services
1
2013
1
0.430
Why?
Schools, Pharmacy
1
2013
22
0.420
Why?
Diabetes Mellitus, Type 2
1
2017
324
0.420
Why?
Interprofessional Relations
4
2017
63
0.400
Why?
Learning
2
2010
95
0.390
Why?
Diuretics
1
2011
12
0.380
Why?
Thromboembolism
1
2011
57
0.380
Why?
Aged
9
2023
5222
0.360
Why?
Heparin, Low-Molecular-Weight
1
2010
35
0.340
Why?
Secondary Prevention
1
2010
44
0.340
Why?
Cardiovascular Agents
1
2010
22
0.340
Why?
Dabigatran
3
2014
20
0.330
Why?
Educational Measurement
4
2014
125
0.290
Why?
Aging
1
2014
952
0.270
Why?
Cardiovascular Diseases
1
2010
353
0.260
Why?
Time Factors
4
2017
1570
0.260
Why?
Pharmacists
2
2017
69
0.240
Why?
Female
8
2017
14636
0.230
Why?
Feedback
2
2014
32
0.230
Why?
Administration, Oral
2
2017
166
0.230
Why?
Streptococcus pneumoniae
1
2023
28
0.210
Why?
Faculty
3
2013
61
0.190
Why?
Male
6
2017
13022
0.170
Why?
Adult
5
2017
7492
0.170
Why?
Aged, 80 and over
3
2014
1940
0.170
Why?
Nephritis, Interstitial
1
2018
2
0.160
Why?
Practice Guidelines as Topic
2
2010
234
0.150
Why?
Fractures, Bone
1
2018
43
0.150
Why?
Clostridium Infections
1
2018
66
0.150
Why?
Health Knowledge, Attitudes, Practice
2
2011
282
0.150
Why?
Insulin, Long-Acting
1
2017
4
0.140
Why?
Insulin Glargine
1
2017
6
0.140
Why?
Influenza Vaccines
1
2017
48
0.140
Why?
Blood Coagulation Tests
1
2017
27
0.140
Why?
Glycated Hemoglobin A
1
2017
64
0.130
Why?
Universities
1
2017
115
0.130
Why?
Hypoglycemia
1
2017
34
0.130
Why?
Health Personnel
1
2017
91
0.130
Why?
Medication Adherence
1
2017
46
0.130
Why?
Physicians
1
2017
80
0.130
Why?
Retrospective Studies
2
2013
2454
0.130
Why?
OX40 Ligand
1
2015
16
0.130
Why?
Homozygote
1
2015
36
0.130
Why?
Hematologic Neoplasms
1
2015
18
0.120
Why?
Blood Glucose
1
2017
307
0.120
Why?
Problem Solving
2
2013
28
0.120
Why?
Randomized Controlled Trials as Topic
1
2017
364
0.120
Why?
Prescription Drug Diversion
1
2014
1
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2015
68
0.120
Why?
Dosage Forms
1
2014
5
0.120
Why?
Drug and Narcotic Control
1
2014
6
0.120
Why?
Renal Insufficiency
1
2014
20
0.120
Why?
Chemistry, Pharmaceutical
1
2014
26
0.120
Why?
Pharmacies
1
2014
19
0.120
Why?
Drug Prescriptions
1
2014
43
0.110
Why?
Medication Errors
1
2014
26
0.110
Why?
Rivaroxaban
1
2014
28
0.110
Why?
Cooperative Behavior
1
2014
74
0.110
Why?
Adverse Drug Reaction Reporting Systems
1
2013
13
0.110
Why?
Teaching
1
2014
76
0.110
Why?
Recurrence
1
2014
316
0.110
Why?
Fatal Outcome
1
2013
66
0.110
Why?
Surveys and Questionnaires
1
2017
930
0.110
Why?
Pulmonary Embolism
1
2014
126
0.110
Why?
Problem-Based Learning
1
2013
60
0.110
Why?
Diphosphonates
1
2013
14
0.100
Why?
Program Development
2
2010
75
0.100
Why?
Child
3
2015
2160
0.100
Why?
Health Occupations
2
2009
8
0.100
Why?
Kidney
1
2014
276
0.100
Why?
Databases, Factual
1
2013
251
0.100
Why?
Osteoporosis
1
2013
63
0.100
Why?
International Normalized Ratio
1
2011
27
0.100
Why?
Drug Interactions
1
2011
77
0.090
Why?
Cohort Studies
1
2013
863
0.090
Why?
Attitude of Health Personnel
1
2011
139
0.090
Why?
Receptors, CCR5
1
2010
4
0.090
Why?
Tissue Donors
1
2010
24
0.080
Why?
Bone Marrow Transplantation
1
2010
42
0.080
Why?
Education, Professional
1
2009
5
0.080
Why?
Staff Development
1
2009
7
0.080
Why?
Program Evaluation
1
2010
162
0.080
Why?
Haplotypes
1
2010
279
0.080
Why?
Risk Factors
1
2014
2030
0.080
Why?
Oklahoma
1
2011
978
0.070
Why?
Middle Aged
3
2015
6900
0.070
Why?
Vaccines, Conjugate
1
2023
3
0.050
Why?
Pneumococcal Vaccines
1
2023
20
0.050
Why?
Disease-Free Survival
2
2015
225
0.050
Why?
Infant
2
2015
966
0.040
Why?
Child, Preschool
2
2015
1100
0.040
Why?
Oncogene Proteins v-myb
1
2015
2
0.030
Why?
Adolescent
2
2015
2988
0.030
Why?
HLA Antigens
1
2015
61
0.030
Why?
Antigens, CD
1
2015
134
0.030
Why?
Survival Rate
1
2015
411
0.030
Why?
Group Processes
1
2013
8
0.030
Why?
Case-Control Studies
1
2015
705
0.030
Why?
B-Lymphocytes
1
2015
277
0.030
Why?
Bisphosphonate-Associated Osteonecrosis of the Jaw
1
2013
3
0.030
Why?
Femoral Fractures
1
2013
10
0.030
Why?
Polymorphism, Single Nucleotide
1
2015
537
0.030
Why?
Gastrointestinal Neoplasms
1
2013
34
0.030
Why?
Transplantation Conditioning
1
2010
12
0.020
Why?
Students, Health Occupations
1
2009
10
0.020
Why?
Professional Competence
1
2009
36
0.020
Why?
Multivariate Analysis
1
2010
299
0.020
Why?
Atrial Fibrillation
1
2013
398
0.020
Why?
Young Adult
1
2010
2626
0.010
Why?
Conway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (137)
Explore
_
Co-Authors (4)
Explore
_
Similar People (57)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_